Guardant Health (GH) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US40131M1099

Guardant Health, Inc. is a company dedicated to precision oncology. Based in Palo Alto, California, they operate worldwide, offering innovative blood tests, data solutions, and analytics to aid in cancer detection and treatment.

One of their flagship offerings is Guardant360, a comprehensive test that analyzes genetic markers to guide personalized treatment decisions. They also provide other specialized tests like GuardantOMNI for advanced cancer stages and Shield Test for early-stage treatment selection.

In addition to their testing services, Guardant Health also develops software solutions such as GuardantConnect, which helps connect patients with actionable alterations to relevant clinical studies, enhancing patient care and treatment outcomes.

The company has a strong emphasis on research and collaboration, partnering with prestigious organizations like the Parker Institute for Cancer Immunotherapy to study the impact of molecular cancer biomarkers on patient response to immunotherapy across diverse cancer types.

Guardant Health, Inc. aims to revolutionize cancer care through cutting-edge technologies and collaborative research efforts, making significant strides in advancing precision oncology globally. To learn more about their groundbreaking work, you can visit their website at

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Guardant Health (GH) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Guardant Health (GH) - Stock Price & Dividends

GH Stock Overview

Market Cap in USD 2,511m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Health Care Services
TER 0.00%
IPO / Inception 2018-10-04

GH Stock Ratings

Growth 5y -5.32
Fundamental -5.02
Dividend -
Rel. Performance vs Sector -4.52
Analysts 4.55/5
Fair Price Momentum 13.27 USD
Fair Price DCF -

GH Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

GH Growth Ratios

Growth 12m -32.24%
Growth Correlation 12m -54%
Growth Correlation 3m -63%
CAGR 5y -23.53%
Sharpe Ratio 12m -0.64
Alpha vs SP500 12m -61.46
Beta vs SP500 5y weekly 1.35
ValueRay RSI 29.90
Volatility GJR Garch 1y 77.36%
Price / SMA 50 -13.94%
Price / SMA 200 -38.21%
Current Volume 1580.6k
Average Volume 20d 2440.6k

External Links for GH Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of GH stocks?
As of April 19, 2024, the stock is trading at USD 16.67 with a total of 1,580,580 shares traded.
Over the past week, the price has changed by -10.76%, over one month by -4.47%, over three months by -29.63% and over the past year by -32.10%.
What is the forecast for GH stock price target?
According to ValueRays Forecast Model, GH Guardant Health will be worth about 14.6 in April 2025. The stock is currently trading at 16.67. This means that the stock has a potential downside of -12.54%.
Issuer Forecast Upside
Wallstreet Target Price 39.9 139.2%
Analysts Target Price 53 217.9%
ValueRay Target Price 14.6 -12.5%